• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[坦索罗辛治疗急性尿潴留患者后无导尿管试验失败的预测预后因素。]

[Prognostic factors predicting failure of the trial without catheter after tamsulosin in patients with acute urinary retention.].

作者信息

Farelo-Trejos Oscar Luis, Paesano Nahuel Eduardo, Serna-Hurtado Juan José, García Mauro Fabián, Monzó-Gardiner Juan Ignacio

机构信息

Servicio de Urología. Hospital de Trauma y Emergencias Dr. Federico Abete de Malvinas Argentinas. Buenos Aires. Argentina.

出版信息

Arch Esp Urol. 2017 Nov;70(9):759-765.

PMID:29099378
Abstract

OBJECTIVE

To analyze prognostic variables that impact on the trial without catheter after tamsulosin in patients with acute urine retention.

METHODS

Retrospective analysis of a prospective database of a cohort of successive patients with acute urinary retention due to benign prostatic hyperplasia attended at the urology emergency room during one year time period. We analyzed the clinical and radiological characteristics and the international prostatic symptom score questionnaire of a total 65 male patients.

RESULTS

The trial without catheter after tamsulosin showed positive results in 25 patients (38%) and failed in the remaining 40 (62%). In multivariate analysis, none of the analyzed variables resulted in an independent predictive factor for spontaneous micturition after the trial without catheter. However, the severe IPSS (p=0.085) presented an important statistical tendency for predicting failure of spontaneous micturition, as well as we found that the 84% of diabetic patients presented failure to the trial with catheter.

CONCLUSIONS

The only variable that impact negatively on the trial without catheter was the severe IPSS with an approximation to statistical significance. The presence of diabetes as a related factor is a hypothesis that should be investigated with a higher number of cases.

摘要

目的

分析影响坦索罗辛治疗后急性尿潴留患者无导尿管试验的预后变量。

方法

对泌尿外科急诊室在一年时间内连续收治的因良性前列腺增生导致急性尿潴留的患者队列的前瞻性数据库进行回顾性分析。我们分析了总共65例男性患者的临床和放射学特征以及国际前列腺症状评分问卷。

结果

坦索罗辛治疗后无导尿管试验在25例患者(38%)中显示出阳性结果,其余40例(62%)失败。在多变量分析中,所分析的变量均未成为无导尿管试验后自主排尿的独立预测因素。然而,严重的国际前列腺症状评分(p = 0.085)在预测自主排尿失败方面呈现出重要的统计学趋势,并且我们发现84%的糖尿病患者无导尿管试验失败。

结论

对无导尿管试验产生负面影响的唯一变量是严重的国际前列腺症状评分,接近统计学意义。糖尿病作为相关因素的存在是一个应通过更多病例进行研究的假设。

相似文献

1
[Prognostic factors predicting failure of the trial without catheter after tamsulosin in patients with acute urinary retention.].[坦索罗辛治疗急性尿潴留患者后无导尿管试验失败的预测预后因素。]
Arch Esp Urol. 2017 Nov;70(9):759-765.
2
Factors predicting the success of a trial without catheter in acute urinary retention secondary to benign prostatic hyperplasia.预测良性前列腺增生继发急性尿潴留无导尿管试验成功的因素。
Nepal Med Coll J. 2011 Sep;13(3):178-81.
3
A comparative study on the use of tamsulosin versus alfuzosin in spontaneous micturition recovery after transurethral catheter removal in patients with benign prostatic growth.坦索罗辛与阿夫唑嗪用于良性前列腺增生患者经尿道拔除导尿管后自主排尿恢复的比较研究
Int Urol Nephrol. 2014 Apr;46(4):687-90. doi: 10.1007/s11255-013-0515-y. Epub 2013 Sep 24.
4
Role of combined use of ketoconazole and tamsulosin in management of acute urinary retention due to benign prostatic obstruction (a randomized controlled trial).酮康唑和坦索罗辛联合应用在良性前列腺增生引起的急性尿潴留治疗中的作用(一项随机对照试验)。
Prostate Cancer Prostatic Dis. 2013 Dec;16(4):362-6. doi: 10.1038/pcan.2013.30. Epub 2013 Sep 10.
5
[Tamsulosin in the treatment of benign prostatic hyperplasia patients with acute urinary retention].坦索罗辛治疗良性前列腺增生合并急性尿潴留患者
Zhonghua Nan Ke Xue. 2003 Oct;9(7):510-1.
6
Effectiveness of the addition of tadalafil to tamsulosin in the treatment of acute urinary retention in patients with benign prostatic hyperplasia: A randomized clinical trial.他达拉非联合坦索罗辛治疗良性前列腺增生患者急性尿潴留的有效性:一项随机临床试验。
Urologia. 2018 May;85(2):51-54. doi: 10.1177/0391560317749427. Epub 2018 Mar 26.
7
Prospective randomized placebo-controlled study to assess the safety and efficacy of silodosin in the management of acute urinary retention.前瞻性随机安慰剂对照研究评估了 silodosin 在急性尿潴留治疗中的安全性和有效性。
Urology. 2013 Jul;82(1):171-5. doi: 10.1016/j.urology.2013.02.020. Epub 2013 Apr 3.
8
Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4-year results from the randomized, double-blind Combination of Avodart and Tamsulosin (CombAT) trial.联合治疗比单独治疗对前列腺增生(BPH)患者的临床效果:基线特征的 4 年随机、双盲阿夫唑嗪和坦索罗辛联合治疗(CombAT)试验结果。
BJU Int. 2011 Mar;107(6):946-54. doi: 10.1111/j.1464-410X.2011.10124.x. Epub 2011 Feb 18.
9
[Clinical outcomes after combined therapy with dutasteride in patients with unsuccessful trial without catheter after treatment with an alpha1-adrenergic receptor blocker monotherapy for acute urinary retention caused by prostatic hyperplasia].
Nihon Hinyokika Gakkai Zasshi. 2014 Oct;105(4):190-5. doi: 10.5980/jpnjurol.105.190.
10
Tamsulosin in the management of patients in acute urinary retention from benign prostatic hyperplasia.坦索罗辛用于治疗良性前列腺增生导致急性尿潴留的患者。
BJU Int. 2005 Feb;95(3):354-7. doi: 10.1111/j.1464-410X.2005.05299.x.

引用本文的文献

1
Immediate or delayed trial without catheter in acute urinary retention in males: A systematic review.男性急性尿潴留无导尿管即刻或延迟试验:一项系统评价
BJUI Compass. 2024 May 14;5(8):732-747. doi: 10.1002/bco2.369. eCollection 2024 Aug.